Home / Business / Stocks rise as AstraZeneca resumes vaccine trials

Stocks rise as AstraZeneca resumes vaccine trials



AZN.L) and the University of Oxford have confirmed plans to resume a major coronavirus vaccine study. “data-reactid =” 23 “> Stocks increased worldwide on Monday after AstraZeneca (AZN.L) and the University of Oxford confirmed plans to resume a major coronavirus vaccine study.

Investors welcomed the late-stage restart of the study, which had been paused last week after a study patient reported a side effect.

The University of Oxford announced over the weekend that clinical trials would resume in the UK with regulatory approval.

“Globally, approximately 18,000 people received study vaccines as part of the trial. In large trials like this, some participants are expected to become ill and each case will need to be carefully evaluated to ensure a careful safety assessment, ”the university said in a statement.

Week ahead: BoE meeting, Fed in the spotlight and latest Brexit“data-reactid =” 31 “>READ MORE: Week ahead: BoE meeting, Fed in the spotlight and latest Brexit

^ FTSE) jumped 0.8% when the markets opened. The European Stoxx 50 index at European level (^ STOXX50E), The German DAX (^ GDAXI) and the French CAC 40 (^ FCHI) all increased by 0.9%. “data-reactid =” 32 “> In Great Britain the FTSE 100 (^ FTSE) jumped 0.8% as the markets opened. The European Stoxx 50 (^ STOXX50E), the German DAX (^ GDAXI) and France’s CAC 40 (^ FCHI) increased by 0.9%.

“European equities got off to a good start to the week helped by a decent performance in Asia, as well as renewed optimism about progress on a possible vaccine after AstraZeneca resumed its testing in the UK following last week’s suspension over safety concerns and possible side effects, “said Michael Hewson, chief market analyst at CMC Markets UK.

“The CEO of US pharmaceutical giant Pfizer has also been optimistic that US citizens will see the start of a Covid vaccine by the end of the year,” he added.

Several high-profile corporate deals also added to sentiment. “The mergers and acquisitions activity showed that there was still some life in the market,” said Russ Mold, investment director at AJ Bell.

Along with US pharmaceutical giant Gilead which bought a cancer specialist for about $ 20 billion, Japanese investor Softbank announced that it would sell British microchip designer ARM to US-based Nvidia for $ 40 billion.

“The biggest deal in terms of market sentiment was Oracle’s partnership with Chinese social media platform TikTok, which helped ease concerns about the US-China on-off trade war.”

ES = F) traded 1.4% higher, Dow Jones futures (YM = F) was up 1.2% and Nasdaq futures (NQ = F) recorded a jump of 1.8%. “data-reactid =” 38 “> US equities looked set to jump to open later on Monday. S&P 500 futures (ES = F) traded 1.4% higher, Dow Jones futures (YM = F) went up 1.2% and Nasdaq futures (NQ = F) went up 1.8%.

^ N225) and the Hong Kong Hang Seng (^ HSI) rose by 0.7%, while in China the Shanghai Composite (000001.SS) and the Shenzen component (399001.SZ) both increased by 0.6%. “data-reactid =” 39 “> Asian markets also rallied overnight. Japan’s Nikkei (^ N225) and Hong Kong’s Hang Seng (^ HSI) rose 0.7%, while in China Shanghai Composite (000001 .SS) and Shenzen component (399001.SZ) both increased by 0.6%.


Source link